Solara Active Pharma Sciences Ltd - 541540 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Solara Active Pharma Sciences Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Solara Active Pharma Sciences Ltd - 541540 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Submission of Voting Results of the 5th Annual General Meet ing Ref: Reg. 44 of SEBI (Listing Obligat ions and Disclosure Requirements) Regulations, 2015. Solara Active Pharma Sciences Ltd - 541540 - Shareholder Meeting / Postal Ballot-Outcome of AGM
We wish to inform you that the Fifth Annual General Meeting ('AGM') of the Company was held on Thursday, August 25, 2022, through Video Conferencing. Please find attached the summary of proceedings of the AGM as required under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Solara Active Pharma Sciences Ltd - 541540 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on August 23, 2022 for Chayadeep Ventures LLP Solara Active Pharma Sciences Ltd - 541540 - Withdrawal Of Resolution No. 3 Of The Notice Dated April 29, 2022, Convening The Fifth Annual General Meeting Of The Company
This is in continuation to our letter dated August 4, 2022, informing about the cessation of directorship of Mr. Kartheek Raju (DIN: 02921819) as a Director of the Company pursuant to his resignation on August 3, 2022. Consequent to above, Resolution No. 3 of the Notice of Fifth Annual General Meeting scheduled to be held on August 25, 2022, to resolved that "To appoint a director in place of Mr. Kartheek Raju Chintalapati (holding DIN 02921819) who retires by rotation and being eligible offers himself for reappointment as Non-Executive Director of the Company" has become redundant and stands withdrawn. Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Please find enclosed herewith transcript of the Earnings Call held on August 4, 2022. Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement - Unaudited Financial Results for the quarter ended June 30, 2022 Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement - Unaudited Financial Results for the quarter ended June 30, 2022 Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
We wish to inform you that we have uploaded audio recording of the Q1 of FY23 Earnings Call held on August 4, 2022, on our Company website. Solara Active Pharma Sciences Ltd - 541540 - Announcement under Regulation 30 (LODR)-Resignation of Director
We wish to inform you that Mr. Kartheek Raju, Non-executive (Non-independent) director has resigned with effect from August 3, 2022. We also wish to inform you that the Nomination & Remuneration Committee of the Board of Directors of the Company has granted 30,000 stock options under Solara Employee Stock Option Plan 2018 to an eligible employee.